Editorial: Moving beyond the molecular mechanisms of malignant pleural mesothelioma: Cues for novel biomarkers and drug targets

Front Oncol. 2023 Mar 6:13:1163144. doi: 10.3389/fonc.2023.1163144. eCollection 2023.

Ilaria Cavallari¹, Ferdinando Cerciello², Elisa Giovannetti^{3

4}, Loredana Urso^{1

5}

¹ Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto - Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padua, Italy.
² Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
³ Laboratory Medical Oncology, Department Medical Oncology, Cancer Center Amsterdam, Amsterdam Universitair Medische Centra (UMC), Vrije Universiteit, Amsterdam, Netherlands.
⁴ Cancer Pharmacology Lab, Fondazione Pisana per la Scienza, Pisa, Italy.
⁵ Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.

No abstract available

Keywords: MPM; biomarkers; data-repository; omics data analysis; target therapies.

Publication types